Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 3
Multicenter, Safety Follow-up Study to Assess Safety of Prior Treatment With Romosozumab in Children and Adolescents With Osteogenesis Imperfecta
The primary objective of this trial is to evaluate the safety of romosozumab in participants with osteogenesis imperfecta (OI) that have completed Study 202001…
Osteogenesis Imperfecta
Estimated
~$10 – $7,500
AmgenNCT07366086
Phase 2
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Efficacy of AGA2115 in Adults With Type I, III, or IV Osteogenesis Imperfecta (OI)
This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.
Osteogenesis Imperfecta (OI)
Estimated
~$10 – $8,750
Angitia Incorporated LimitedNCT07062588
Rare Diseases Clinical Research Network Brittle Bone Disease Consortium Longitudinal Study of Osteogenesis Imperfecta
Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta…
Osteogenesis Imperfecta
Estimated
~$10 – $750
Baylor College of MedicineNCT02432625
Phase 4
Effects of Bisphosphonates on OI-Related Hearing Loss: A Pilot Study
Osteogenesis Imperfecta-related hearing loss usually occurs in individuals with mild (type I) OI and is much earlier in onset than age-related hearing loss, wi…
Osteogenesis Imperfecta
Estimated
~$10 – $6,250
Hospital for Special Surgery, New YorkNCT04152551